it had the potential to cure PV. This Figure 4. Target platelet count in polycythemia vera. perception is in keeping with clinical data regarding improvement in symptom burden. In the more than 10 years since the prior survey
Search Results
Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post–JAK2 V617F Discovery Era
Elizabeth M. Kander, Alison R. Moliterno, Alfred Rademaker, Michael B. Streiff, Jerry L. Spivak, and Brady L. Stein
Value Tools for Patients in Cancer Care
Katy Winckworth-Prejsnar, Lisa Korin Lentz, Elizabeth A. Nardi, Sandhya Pruthi, C. Lyn Fitzgerald, and Robert W. Carlson
. Zafar Y Goetzinger AM Fowler R . Impact of out-of-pocket expenses on cancer care [abstract] . J Clin Oncol 2011 ; 29 ( Suppl ): Abstract 6006 . 8. Lathan C Cronin A Tucker-Seeley R . Association of financial strain with symptom burden and
By the Pricking of My Thumbs, Something Wicked This Way Comes: Sporadic Cancers Versus Eponymous Hereditary Cancer Predisposition Syndromes
Christos Vaklavas, John R. Ross, Lisle M. Nabell, Andres Forero, Martin J. Heslin, and Tina E. Wood
developed later, a striking contradiction was noted between the extent of disease and the patient's minimal symptom burden. Physical examination was negative for abnormal findings. A thorough family history was unrevealing. She had one brother, who was
Barriers and Approaches to the Successful Integration of Palliative Care and Oncology Practice
Jamie H. Von Roenn, Raymond Voltz, and Alain Serrie
any patient with metastatic cancer and/or high symptom burden. 3 The Associazione Italiana di Oncologia Medica has stated that “taking care of patients with cancer means not only to offer them the best therapeutic options but also to understand and
Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer
Emily J. Martin, Andrew R. Bruggeman, Vinit V. Nalawade, Reith R. Sarkar, Edmund M. Qiao, Brent S. Rose, and James D. Murphy
Background Most patients with esophageal cancer are found to have locally advanced or metastatic disease at the time of initial diagnosis. 1 – 4 Such advanced disease is associated with significant symptom burden and corresponding decrease in
Durable Response to PD-1 Blockade in a Patient With Metastatic Pancreatic Undifferentiated Carcinoma With Osteoclast-Like Giant Cells
Robert J. Besaw, Adrienne R. Terra, Grace L. Malvar, Tobias R. Chapman, Lauren M. Hertan, and Benjamin L. Schlechter
compression and pain, reducing the patient’s ability to eat. She was referred for palliative RT to mitigate her symptom burden due to mass effect. Given limited data regarding the efficacy of RT in UCOGC histology, but due to the presence of spindle cell
Clinical Impact of Local Progression in Pancreatic Cancer
Nicholas Cardillo, Daniel M. Seible, Katherine E. Fero, Andrew R. Bruggeman, Reith R. Sarkar, Alexa Azuara, Daniel R. Simpson, and James D. Murphy
cancer at a single academic institution from 2004 through 2015 were retrospectively reviewed. Available medical records, pathology, and radiology reports were reviewed in entirety, with a focus on defining the symptom burden that patients experience with
Addressing Survivorship in Cancer Care
James McCanney, Katy Winckworth-Prejsnar, Alyssa A. Schatz, Elizabeth A. Nardi, Andrea J. Dwyer, Christopher Lieu, Yelak Biru, and Robert W. Carlson
focused on QoL, symptom burden, and economic implications of treatment, among other outcomes. Emphasis is given to ensure the medical community's focus is not on cure at any cost. Providers must better understand QoL after treatment, patient values
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non–Small Cell Lung Cancer
Matthew A. Gubens and Marianne Davies
high PD-L1 expression (ie, those with a high disease or symptom burden), with KEYNOTE-189 showing improved OS compared with chemotherapy alone. 4 Although this regimen carries greater toxicity than pembrolizumab alone, clinicians and patients may
A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers
Kate Watabayashi, Jordan Steelquist, Karen A. Overstreet, Anthony Leahy, Erin Bradshaw, Kathleen D. Gallagher, Alan J. Balch, Rebecca Lobb, Laura Lavell, Hannah Linden, Scott D. Ramsey, and Veena Shankaran
; 32 : 306 – 311 . 10.1200/JCO.2013.52.9123 24366936 2. Lathan CS , Cronin A , Tucker-Seeley R , . Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer . J Clin Oncol 2016 ; 34
